中医治疗在ICU获得性衰弱治疗中的Meta分析
该系统评价检索了PubMed、Cochrane Library、Embase、Web of Science、CNKI、万方、维普数据库,检索时间从建库至2021年12月,纳入13项中医治疗ICU获得性衰弱的随机对照试验,共982例患者(试验组562例,对照组420例)。Meta分析显示,中医治疗可提高临床疗效(RR=1.35,95%CI 1.20~1.52,P<0.000 01),改善肌力(MRC评分SMD=1.00,95%CI 0.67~1.33,P<0.000 01)和日常生活能力(MBI评分SMD=1.67,95%CI 1.20~2.14,P<0.000 01),缩短机械通气时间(SMD=-1.47,95%CI -1.84~-1.09,P<0.000 01)、ICU住院时间(MD=-3.28,95%CI -3.89~-2.68,P<0.000 01)和总住院时间(MD=-4.71,95%CI -5.90~-3.53,P<0.000 01),降低TNF-α(MD=-4.55,95%CI -6.39~-2.70,P<0.000 01)和IL-6(MD=-5.07,95%CI -6.36~-3.77,P<0.000 01)。但在降低疾病严重程度方面无显著优势(APACHE II评分SMD=-0.45,95%CI -0.92~0.03,P=0.07)。
要点
- 中医治疗可提高ICU-AW临床疗效(RR=1.35,95%CI 1.20~1.52,P<0.000 01),并改善MRC肌力评分(SMD=1.00,95%CI 0.67~1.33,P<0.000 01)。
- 中医治疗可缩短机械通气时间(SMD=-1.47,95%CI -1.84~-1.09,P<0.000 01)和ICU住院时间(MD=-3.28,95%CI -3.89~-2.68,P<0.000 01)。
- 中医治疗可改善MBI日常生活能力评分(SMD=1.67,95%CI 1.20~2.14,P<0.000 01),并缩短总住院时间(MD=-4.71,95%CI -5.90~-3.53,P<0.000 01)。
- 中医治疗可降低TNF-α(MD=-4.55,95%CI -6.39~-2.70,P<0.000 01)和IL-6(MD=-5.07,95%CI -6.36~-3.77,P<0.000 01)。
- 中医治疗未显著降低APACHE II疾病严重程度评分(SMD=-0.45,95%CI -0.92~0.03,P=0.07)。
适用人群与场景
- ICU获得性衰弱(ICU-AW)患者,纳入13项随机对照试验共982例,试验组562例,对照组420例。
研究设计与关键结果
- 研究类型为Meta分析,共纳入13项随机对照试验、982例患者(试验组562例,对照组420例);检索PubMed、Cochrane Library、Embase、Web of Science、CNKI、万方、维普数据库,检索时间从建库至2021年12月。
- 中医治疗提高ICU-AW临床疗效(RR=1.35,95%CI 1.20~1.52,P<0.000 01),改善MRC肌力评分(SMD=1.00,95%CI 0.67~1.33,P<0.000 01)和MBI日常生活能力评分(SMD=1.67,95%CI 1.20~2.14,P<0.000 01)。
- 中医治疗缩短机械通气时间(SMD=-1.47,95%CI -1.84~-1.09,P<0.000 01)、ICU住院时间(MD=-3.28,95%CI -3.89~-2.68,P<0.000 01)和总住院时间(MD=-4.71,95%CI -5.90~-3.53,P<0.000 01)。
- 中医治疗降低TNF-α(MD=-4.55,95%CI -6.39~-2.70,P<0.000 01)和IL-6(MD=-5.07,95%CI -6.36~-3.77,P<0.000 01)。
- 中医治疗在降低APACHE II疾病严重程度方面无显著优势(SMD=-0.45,95%CI -0.92~0.03,P=0.07)。
证据类型、等级与局限
- 证据类型为Meta分析,纳入13项随机对照试验;作者结论:基于目前研究,中医治疗可改善ICU-AW临床疗效、肌力和日常生活能力,缩短机械通气时间、ICU住院时间和总住院时间,降低TNF-α和IL-6,但不能降低整体疾病严重程度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 基于现有研究,中医治疗可能改善ICU-AW患者的临床疗效、肌力与日常生活能力,缩短机械通气时间和ICU住院时间;但对疾病严重程度无显著改善。
- 作者认为中医治疗可改善ICU-AW的临床疗效,但未给出具体中医治疗方案、药物剂量或推荐等级。
指南或共识出处
- 中华危重病急救医学(Zhonghua Wei Zhong Bing Ji Jiu Yi Xue)发表的Meta分析,检索截止2021年12月。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically assess the efficacy of traditional Chinese therapy in the treatment of ICU-acquired weakness (ICU-AW).
METHODS: PubMed, Cochrane Library, Embase, Web of Science, CNKI, Wanfang, VIP were retrieved by computer and were used to collect a randomized controlled trials (RCT) of traditional Chinese therapy for ICU-AW. The retrieval time was from databases establishment to December 2021. After 2 researchers independently screened the literature, extracted data and evaluated the risk of bias included in the study, and RevMan 5.4 software was used for Meta-analysis.
RESULTS: 334 articles were selected, totally 13 clinical studies and 982 patients were included, including 562 in the trial group and 420 in the control group. Meta-analysis results showed that traditional Chinese therapy could improve clinical efficacy of ICU-AW patients [relative risk (RR) = 1.35, 95% confidence interval (95%CI) was 1.20 to 1.52, P < 0.000 01], improve the muscle strength [Medical Research Council score (MRC score); standardized mean difference (SMD) = 1.00, 95%CI was 0.67 to 1.33, P < 0.000 01], improve daily life ability [modified Barthel index score (MBI score); SMD = 1.67, 95%CI was 1.20 to 2.14, P < 0.000 01], shorten mechanical ventilation time (SMD = -1.47, 95%CI was -1.84 to -1.09, P < 0.000 01), reduce the length of intensive care unit (ICU) stay [mean difference (MD) = -3.28, 95%CI was -3.89 to -2.68, P < 0.000 01], reduce the total hospitalization time (MD = -4.71, 95%CI was -5.90 to -3.53, P < 0.000 01), reduce tumor necrosis factor-α (TNF-α; MD = -4.55, 95%CI was -6.39 to -2.70, P < 0.000 01) and interleukin-6 (IL-6; MD = -5.07, 95%CI was -6.36 to -3.77, P < 0.000 01). There was no obvious advantage in reducing the severity of the disease [acute physiology and chronic health evaluation II (APACHE II; SMD = -0.45, 95%CI was -0.92 to 0.03, P = 0.07).
CONCLUSIONS: Based on the current research, traditional Chinese therapy can improve the clinical efficacy of ICU-AW, improve muscle strength and daily life ability, shorten mechanical ventilation, the length of ICU stay and total hospitalization time, reduce TNF-α and IL-6. But traditional Chinese therapy can not reduce the overall disease severity.
参考来源
- Zhou X, Jin Y, Liu L, et al. [Traditional Chinese therapy in the treatment of ICU-acquired weakness: a Meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37308238. doi:10.3760/cma.j.cn121430-20220301-00191
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。